Skip to main content

Table 6 Comparison of miR-31 and miR-373 expressions based on several clinicopathological factors in CRC patients

From: Correlation of miR-31 and miR-373 expression with KRAS mutations and its impact on prognosis in colorectal cancer

Clinicopathological factors

miR-31

miR-373

Lymph node involvement

Yes

0.88 (0.11–1.78)

0.81 (0.01–1.42)

No

0.93 (0.14–1.86)

0.83 (0.11–1.76)

P value=0.81

P value=0.66

Distance metastasis

Yes

1.02 (0.06–2.01)

1.00 (0.1–2.21)

No

0.98 (0.51–1.68)

0.81 (0.3–1.55)

P value=0.74

P value=0.54

Tumor diameter

<40 mm

1.12 (0.81–2.22)

1.02 (0.3–1.99)

>40 mm

1.02 (0.75–1.99)

0.99 (0.42–1.78)

P value=0.88

P value=0.66

Tumor location

Proximal colon

0.97 (0.41–1.66)

1.31 (0.31–2.43)

Distal colon

0.99 (0.45–1.76)

1.22 (0.65–2.00)

P value=0.5

P value=0.88

Tumor differentiation

Well

3.1 (1.5–4.43)

8.1 (2.31–10.22)

Moderate

0.91 (0.81–1.87)

1.44 (0.88–2.76)

Poor

0.5 (0.1–1.1)

0.88 (0.11–1.99)

 

P value=0.001

P value=0.001